Search for: [Abstract = "STICA 6.1 \(Stat. Soft USA\) was used for statistical analysis. Results 89 patients aged 43\-75 years \(mean 61.7\) were included in the study. The group of patients undergoing SND included 40 patients aged 43\-75 years \(mean age 61.45\) \(11 women \(56\-70\) mean age 61.5 and 29 men \(43\-75\) mean age 61.4. The group of patients subjected to BML was 49 aged 51\-75, mean age 61.0 \(13 women 51\-70 mean age 61.4 and 36 men \(52 \- 75\) mean age 62.4. No statistical difference was found, p = 0.608. Histological distribution of lung cancer in the studied groups. Histology of the primary tumor in the control group\: squamous cell carcinoma \- 32 \(65.3%\), adenocarcinoma 9 \(18.4%\), giant cell carcinoma \- 1 \(2%\), adeno\-squamous cell carcinoma \- 4 \(8.2%\), cancer of the sarcomatic type \- 2 \(4%\), bronchoalveolar cancer \- 1 \(2%\). Primary tumor histology in the study group\: squamous cell carcinoma \- 21 \(52.5%\), adenocarcinoma 16 \(40.0%\), adeno\-squamous \- 2 \(5%\), adenocarcinoma\-giant cell carcinoma 1 \(2.5%\) . Clinical TNM stage. Clinical advancement \(c Stage\) in the SND group\: IA \- 10 \(20.4%\), IB \- 18 \(36.7%\), IIA \- 12 \(25.5%\), IIB \- 6 \(12.2%\), IIIA \- 3 \(6.1%\). Clinical advancement \(c Stage\) in the BML group\: IA \- 11 \(27.5%\), IB \- 12 \(30.0%\), IIA 10 \(25.0%\), IIB \- 4 \(10.0%\), 3 \(7.5%\). There was no statistical difference between the studied stages, p = 0.921. Pathological TNM stage. pStage in the SND"]

Number of results: 1